Suppr超能文献

0.5 特斯拉磁共振乳腺成像。II. 0.5 和 1.5 特斯拉磁共振乳腺成像中鉴别恶性和良性病变的能力

[MR mammography at 0.5 tesla. II. The capacity to differentiate malignant and benign lesions in MR mammography at 0.5 and 1.5 T].

作者信息

Kuhl C K, Kreft B P, Hauswirth A, Gieseke J, Elevelt A, Reiser M, Schild H H

机构信息

Radiologische Universitätsklinik, Rheinische Fredrich-Wilhelms-Universität Bonn.

出版信息

Rofo. 1995 Jun;162(6):482-91. doi: 10.1055/s-2007-1015922.

Abstract

PURPOSE

To determine whether medium field strength (0.5 T) MR mammography is able to differentiate between benign and malignant lesions in the same way as a 1.5 T standard technique.

MATERIAL

In 40 consecutive female patients with nodular lesions, examinations were carried out at 1.5 T (2D-FFE, TR/TE/FA 200/3.9/80) and 0.5 T (3D-FFE, 24/3.4/40).

RESULTS

There was wide spread of the speed of enhancement of malignant tumours for both techniques (44%-145% with signal increase in the first minute of 42%-189%). In 15 out of 17 carcinomas, the rapidity of uptake and final degree of enhancement after contrast was higher during 0.5 T/3D measurements than it was for 1.5 T/2D images. Fibroadenomas and mastopathies showed similar enhancement characteristics for both techniques. Sharply defined "wash-out" was seen only in malignant lesions; it appeared ten times more frequently in the 0.5 T/3D examinations than at 1.5 T/2D.

CONCLUSIONS

The distinction between benign and malignant lesions can be made with more certainty using medium field strength and 3D-FFE sequence than using the 2D high-field standard technique.

摘要

目的

确定中场强(0.5T)乳腺磁共振成像是否能够与1.5T标准技术一样鉴别良性和恶性病变。

材料

对40例连续的有结节性病变的女性患者,分别采用1.5T(二维快速场回波序列,重复时间/回波时间/翻转角200/3.9/80)和0.5T(三维快速场回波序列,24/3.4/40)进行检查。

结果

两种技术的恶性肿瘤强化速度范围均较广(第1分钟信号增加44%-145%,42%-189%)。在17例癌中的15例中,0.5T/三维测量时对比剂摄取速度和最终强化程度高于1.5T/二维图像。纤维腺瘤和乳腺病在两种技术下显示出相似的强化特征。仅在恶性病变中可见明显的“廓清”;其在0.5T/三维检查中出现的频率比1.5T/二维检查高10倍。

结论

与二维高场强标准技术相比,使用中场强和三维快速场回波序列能更准确地区分良性和恶性病变。

相似文献

2
[Dynamic 3D MR mammography using a rapid gradient-echo sequence].
Rofo. 1995 Jan;162(1):13-9. doi: 10.1055/s-2007-1015827.
4
[MR mammography in patients at risk].
Rofo. 1992 Jun;156(6):576-81. doi: 10.1055/s-2008-1032946.
5
[A pharmacokinetic analysis of Gd-DTPA enhancement in MRT in breast carcinoma].
Rofo. 1994 Jun;160(6):518-23. doi: 10.1055/s-2008-1032470.
8
[Technics for the preoperative marking of nonpalpable breast lesions in MRT].
Rofo. 1996 Jul;165(1):84-7. doi: 10.1055/s-2007-1015719.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验